SELLAS Life Sciences (SLS) Asset Utilization Ratio (2013 - 2022)
SELLAS Life Sciences (SLS) posted quarterly Asset Utilization Ratio of 0.04 for Q4 2022, down 82.0% year-over-year from 0.24 in Q4 2021, and up 24.0% quarter-over-quarter from 0.03 in Q3 2022.
SELLAS Life Sciences (SLS) Asset Utilization Ratio (2013 - 2022) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Asset Utilization Ratio for 6 consecutive years, with 0.04 the latest figure, recorded in Q4 2022.
- In Q4 2022, Asset Utilization Ratio fell 82.0% year-over-year to 0.04; the TTM figure through Dec 2022 stood at 0.04 (down 82.0% YoY), while the FY2022 annual figure was 0.04, down 79.85% from the prior year.
- Asset Utilization Ratio climbed to 0.04 in Q4 2022 per SLS's latest filing, from 0.03 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.55 in Q1 2020 and bottomed at 0.03 in Q3 2022.
- Historically, Asset Utilization Ratio has averaged 0.19 across 3 years, with a median of 0.19 in 2020.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio jumped 302.06% — and 2022, when it plunged 85.25%.
- SELLAS Life Sciences' Asset Utilization Ratio stood at 0.06 in 2020, then jumped by 302.06% to 0.24 in 2021, then sank by 82.0% to 0.04 in 2022.
- Business Quant data shows SLS's Asset Utilization Ratio at 0.04 in Q4 2022, 0.03 in Q3 2022, and 0.04 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | 0.23 |
| Jun 30, 2021 | 0.23 |
| Mar 31, 2021 | 0.18 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.20 |
| Jun 30, 2020 | 0.39 |
| Mar 31, 2020 | 0.55 |
| Jun 30, 2015 | 0.10 |
| Mar 31, 2015 | 0.10 |
| Dec 31, 2014 | 0.12 |
| Sep 30, 2014 | 0.12 |
| Jun 30, 2014 | 0.11 |
| Mar 31, 2014 | 0.10 |
| Dec 31, 2013 | 0.10 |
| Sep 30, 2013 | 0.06 |